Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Turning Point Therapeutics Inc (TPTX)

Turning Point Therapeutics Inc (TPTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,189,718
  • Shares Outstanding, K 35,850
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,785 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.67
  • Number of Estimates 4
  • High Estimate -0.63
  • Low Estimate -0.72
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.50 +16.34%
on 01/15/20
66.98 -8.81%
on 02/12/20
+7.25 (+13.47%)
since 01/14/20
3-Month
49.33 +23.82%
on 11/15/19
67.54 -9.56%
on 01/09/20
+11.68 (+23.64%)
since 11/14/19

Most Recent Stories

More News
Turning Point Therapeutics to Participate in Guggenheim Oncology Day

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis,...

TPTX : 61.08 (-1.75%)
Turning Point Therapeutics Names Garry Nicholson to Its Board of Directors

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Garry Nicholson...

TPTX : 61.08 (-1.75%)
TPTX Crosses Above Average Analyst Target

In recent trading, shares of Turning Point Therapeutics Inc have crossed above the average analyst 12-month target price of $60.25, changing hands for $60.45/share. When a stock reaches the target an...

TPTX : 61.08 (-1.75%)
Turning Point Therapeutics Announces Program Updates and Milestones for 2020

-- Repotrectinib Granted Fast Track Designation in Previously Treated ROS1-Positive Advanced Non-Small Cell Lung Cancer Patient Subset; Registrational Phase 2 Study Continues Site Activation and Patient...

TPTX : 61.08 (-1.75%)
Turning Point Therapeutics Announces Management Transition

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that Dr. Jean Cui will step down...

TPTX : 61.08 (-1.75%)
Turning Point Therapeutics Names Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today named Homa Yeganegi as senior vice president,...

TPTX : 61.08 (-1.75%)
The Zacks Analyst Blog Highlights: BYND, ZM, KRTX, TPTX and SILK

The Zacks Analyst Blog Highlights: BYND, ZM, KRTX, TPTX and SILK

KRTX : 99.72 (+3.76%)
TPTX : 61.08 (-1.75%)
ZM : 90.95 (+1.21%)
SILK : 47.11 (-0.15%)
BYND : 116.22 (+3.76%)
5 Best Performing IPOs of 2019

This year's IPOs performed impressively on the back of strong innovation and a solid balance sheet.

UBER : 39.66 (-1.07%)
LYFT : 44.69 (-4.98%)
PINS : 23.22 (-1.36%)
BYND : 116.22 (+3.76%)
TPTX : 61.08 (-1.75%)
SILK : 47.11 (-0.15%)
ZM : 90.95 (+1.21%)
KRTX : 99.72 (+3.76%)
Turning Point Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, announced that President and CEO Athena Countouriotis, M.D., will present...

JPM : 137.46 (-0.30%)
TPTX : 61.08 (-1.75%)
Turning Point (TPTX) Catches Eye: Stock Jumps 6.1%

Turning Point (TPTX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

IRWD : 12.06 (-7.73%)
TPTX : 61.08 (-1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TPTX with:

Business Summary

Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Their internally developed and wholly owned pipeline of next-generation...

See More

Key Turning Points

2nd Resistance Point 63.16
1st Resistance Point 62.12
Last Price 61.08
1st Support Level 60.50
2nd Support Level 59.92

See More

52-Week High 67.54
Last Price 61.08
Fibonacci 61.8% 50.99
Fibonacci 50% 45.88
Fibonacci 38.2% 40.76
52-Week Low 24.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar